These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6509673)

  • 1. [Methods of evaluating drug therapy, particularly in cardiovascular diseases].
    Lövy O; Toman J
    Cesk Zdrav; 1984 Sep; 32(8-9):361-5. PubMed ID: 6509673
    [No Abstract]   [Full Text] [Related]  

  • 2. [Methods of evaluating drug therapy, particularly in cardiovascular diseases].
    Lövy O; Richter M; Cepelík J; Steiner A
    Cesk Zdrav; 1985 Jan; 33(1):34-42. PubMed ID: 3971461
    [No Abstract]   [Full Text] [Related]  

  • 3. [Underutilization of cardiovascular pharmacotherapy: how to pay for it?].
    Wehling M
    Dtsch Med Wochenschr; 2004 Feb; 129(7):330. PubMed ID: 14765334
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug therapy in acute heart and circulatory failure].
    Follath F
    Schweiz Med Wochenschr; 1988 Apr; 118(17):611. PubMed ID: 3381075
    [No Abstract]   [Full Text] [Related]  

  • 5. [The efficacy and safety of the drug treatment of cardiovascular diseases].
    Mazur NA
    Ter Arkh; 1993; 65(8):4-7. PubMed ID: 8211800
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular drug therapy in the elderly.
    Aronow WS; Frishman WH; Cheng-Lai A
    Heart Dis; 2000; 2(2):151-67. PubMed ID: 11728253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differences in the treatment plans of hospitals. Use of antidiabetics and selected cardiovascular drugs at 20 hospitals].
    Haugen O; Hjort PF; Andrew M; Oydvin K
    Tidsskr Nor Laegeforen; 1980 Jun; 100(16):1065-8. PubMed ID: 7414586
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiology drug update. Foreword.
    Crawford MH
    Cardiol Clin; 2008 Nov; 26(4):xi. PubMed ID: 18929226
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse dermatologic effects of cardiovascular drug therapy.
    Brosnan BD; Frishman WH; Sun DK; Grossman M
    Heart Dis; 2000; 2(3):220-47. PubMed ID: 11728264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PHARMAC and cardiovascular health in New Zealand.
    Moodie P
    N Z Med J; 2008 Mar; 121(1270):102-5. PubMed ID: 18364762
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular combinations.
    Glass G
    Nat Rev Drug Discov; 2004 Sep; 3(9):731-2. PubMed ID: 15368657
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cardiovascular pharmacology].
    Ravens U; Erdmann E
    Dtsch Med Wochenschr; 2004 Apr; 129(15):799. PubMed ID: 15054684
    [No Abstract]   [Full Text] [Related]  

  • 13. [Problems in scientific drug therapy from a socio-hygienic point of view].
    Kobler A; Lehmann G
    Z Arztl Fortbild (Jena); 1981 Oct; 75(19):906-8. PubMed ID: 7314685
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescription refill management and its effect on adherence: comment on "the implications of therapeutic complexity on adherence to cardiovascular medications".
    Salanitro AH; Kripalani S
    Arch Intern Med; 2011 May; 171(9):822-3. PubMed ID: 21220643
    [No Abstract]   [Full Text] [Related]  

  • 15. The newest critical care drugs.
    Chase SL
    RN; 1999 May; 62(5):34-9; quiz 40. PubMed ID: 10418524
    [No Abstract]   [Full Text] [Related]  

  • 16. Patterns of cardiovascular drugs prescribed for an elderly Swedish population.
    Ding M; Wang R; Johnell K; Qiu C
    Int J Cardiol; 2014 Dec; 177(3):1091-4. PubMed ID: 25449520
    [No Abstract]   [Full Text] [Related]  

  • 17. [Secondary nutritional and drug prevention of cardiovasculopathies].
    Comi D; Comi AL
    Recenti Prog Med; 1999 Mar; 90(3):155-9. PubMed ID: 10228356
    [No Abstract]   [Full Text] [Related]  

  • 18. Gender-specific prescription for cardiovascular diseases?
    Stramba-Badiale M; Priori SG
    Eur Heart J; 2005 Aug; 26(16):1571-2. PubMed ID: 16030060
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic implications of the gender-specific aspects of cardiovascular disease.
    Regitz-Zagrosek V
    Nat Rev Drug Discov; 2006 May; 5(5):425-38. PubMed ID: 16672926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronobiologic aspects of therapy for cardiovascular diseases].
    Stepień M; Foks-Fratczak A
    Postepy Hig Med Dosw; 1999; 53(3):483-96. PubMed ID: 10424135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.